(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(-0.05%) $0.926
(-0.09%) $10.83
(-0.10%) $0.791
(-0.21%) $92.38
Live Chart Being Loaded With Signals
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy...
Stats | |
---|---|
Today's Volume | 166 631 |
Average Volume | 220 004 |
Market Cap | 36.53M |
EPS | SEK-0.101 ( 2023-11-24 ) |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.700 |
ATR14 | SEK0.0130 (3.79%) |
Klaria Pharma Holding AB Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Klaria Pharma Holding AB Financials
Annual | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-9 000.00 (0.00 %) |
EPS: | SEK-0.360 |
Q4 | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-3 000.00 (0.00 %) |
EPS: | SEK-0.0889 |
Q3 | 2023 |
Revenue: | SEK619 000 |
Gross Profit: | SEK619 000 (100.00 %) |
EPS: | SEK-0.100 |
Q2 | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-2.76M (0.00 %) |
EPS: | SEK-0.0949 |
Financial Reports:
No articles found.
Klaria Pharma Holding AB
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators